Studies measuring patient-level impact (N = 6, 19% of included studies). by Emily M. Jones (21989800)

Factors associated with the increase in albumin levels. by Takao Kato (444325)

Metabolites with increasing levels during the development. by Martin Sládek (130663)

“…<p>Temporal profiles of polar metabolites and lipids with SCN levels significantly increasing from E19 to P28. Rhythmicity was determined by eJTK; full or dashed lines depict the profiles that either did or did not pass the significance threshold (FDR-adjusted <i>P</i> < 0.05), respectively.…”

Associations between COVID-19 related health behaviours and increased weight. by Junjie Huang (3643540)

Associations between COVID-19 related personal experience and increased weight. by Junjie Huang (3643540)

Outcome of COVID-19 ICU patients by priority level in saturation: All priority levels. by Nicolas Donat (15453396)

Subjects:

The list of genes whose expression was largely increased by AdNKX2-1 infection. by Yuko Ito (1976692)

Subjects:

The percentages of genes with largely changed expression after AdNKX2-1 infection. by Yuko Ito (1976692)

Subjects:

Absence of haptoglobin increase in the first 34 weeks of 2020 in the US cohort. by Thierry Poynard (38084)

Map showing prevalence (A), incidence (B), deaths (C), and DALYs (D) rates of chronic obstructive pulmonary disease per 100,000 population among adults aged ≥70 years in 2021, by c... by Kaifang Meng (13848535)

Subjects:

Map showing estimated annual percentage changes of prevalence (A), incidence (B), deaths (C), and DALYs (D) rates of chronic obstructive pulmonary disease among adults aged ≥70 yea... by Kaifang Meng (13848535)

Subjects:

Plasma cytokine levels in COVID-19 patients compared to controls. by Elena Winheim (11296776)

The global numbers of prevalent cases (A), incident cases (B), deaths (C), DALYs (D), and corresponding rates of chronic obstructive pulmonary disease per 100,000 population in old... by Kaifang Meng (13848535)

Subjects:

Effect of state-level mask mandates on COVID-19 outcomes. by Dhaval Adjodah (11014160)

“…We observe the treatment effect to start near zero when mask mandates are introduced (red vertical line) and to gradually increase (i.e. the treatment effect becomes more negative) reaching, 40 days after the introduction of mask mandates, -0.49 standard deviations (95% confidence interval is [-0.61,-0.37], adjusted <i>R</i>² is 0.632 and <i>p</i> < 0.001) for new cases <b>(a)</b>, -2.38 percentage points ([-2.99,-1.78], adjusted <i>R</i>² is 0.698 and <i>p</i> < 0.001) for the proportion of daily hospitalization admissions <b>(b)</b> due to COVID-19, and 0.52 standard deviations (95% confidence interval is [-0.69,-0.35], adjusted <i>R</i>² is 0.537 and <i>p</i> < 0.001) for deaths <b>(c)</b>. …”

Increased IL-17 level in saliva of severe COVID-19 patients associated with higher need for mechanical ventilation and/or death by days 29. by Fatemeh Saheb Sharif-Askari (8195781)

Topic covariate levels (in proportions) after COVID-19 measures, compared to before COVID-19 measures. by Evert Mul (6712097)

Trends of prevalence (A), incidence (B) deaths (C), and DALYs (D) rates of chronic obstructive pulmonary disease per 100,000 population among adults aged ≥70 years by sex and socio... by Kaifang Meng (13848535)

Subjects:

Low levels of platelet-specific transcripts in leukocytes can be due to platelet-leukocyte interactions. by Heather Learnard (22075952)

Subjects:

The level of autophagy increased as propagation of SRBSDV increased over time in viruliferous WBPHs. by Lu Zhang (50563)

IL-6 levels in COVID-19, ARDS, and AKI non-survivors and survivors. by Idham Jaya Ganda (17296044)

Subjects: